Risk stratification based on size of equivocal PI-RADS lesions may safely reduce the number of MRI-targeted biopsies Yazar: D.F. Osses, C. Arsov, L. Schimmöller, P. Albers, M.J. Roobol

Tam Metin Erişim

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate Yazar: M. Boschheidgen, L. Schimmöller, S. Doerfler, R. Al-Monajjed, J. Morawitz, F. Ziayee, D. Mally, M. Quentin, C. Arsov, P. Albers, G. Antoch, T. Ullrich

Tam Metin Erişim

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy Yazar: M Klingebiel, C Arsov, T Ullrich, M Quentin, R Al-Monajjed, D Mally, LM Sawicki, A Hiester, I Esposito, P Albers, G Antoch, L Schimmöller

Tam Metin Erişim

Effect of sexual behavior on prostate-specific antigen levels in middle-aged men screened for prostate cancer: Results from the PROBASE trial Yazar: V.H. Meissner, M. Hollerer, M. Kron, S. Schiele, P. Albers, C. Arsov, M. Kuczyk, F. Imkamp, M. Hohenfellner, V. Schütz, J.E. Gschwend, K. Herkommer

Tam Metin Erişim